课题基金 / 基金详情

Immune Surveillance of Antigen Processing Pathway

Immune Surveillance of Antigen Processing Pathway
抗原加工途径的免疫监视
批准号:
10112811
负责人:
Scheherazade Sadegh-Nasseri
金额:
$55.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-08 至 2024-02-28

项目摘要

项目成果

Scheherazade Sadegh-Nasseri的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project summary The long term goal of our research is to understand and manipulate immune surveillance pathways. The antigen processing pathway yields thousands of peptide/MHC complexes (pMHC I) on the cell surface as potential ligands for CD8+ T cells to allow detection of viruses or cancer. It is now clear that generation of the normal pMHC I repertoire requires peptide trimming in the endoplasmic reticulum (ER) by ERAAP, the ER aminopeptidase associated with antigen processing. The ERAAP is targeted for immune evasion by viruses and polymorphisms in this gene are linked to many autoimmune diseases. It is therefore essential to monitor ERAAP activity to ensure effective immune surveillance by CD8+ T cells. We had discovered earlier that the unique FL9 nona peptide — derived from the Fam49a/b proteins of unknown function — was presented by the non-classical MHC Ib molecule called Qa-1b only in ERAAP- deficient cells. This FL9 peptide/Qa-1 complex, called QFL was recognized by QFL-specific CD8+ T cells which lysed target cells expressing this ligand. Thus QFL- T cells are a mechanism for detecting and eliminating cells with ERAAP-deficiency. The QFL-T cells are relatively abundant, and share key characteristics with other innate-like iNKT (invariant NK T) and MAIT (mucosal - associated invariant T) cells which are also restricted by non-classical MHC Ib molecules and respond to various microbial and self-antigens. Here we propose to fill gaps in our understanding of how the immune system monitors the fidelity of antigen processing in the ER. We hypothesize that QFL-specific CD8+ T cells and the mechanisms for generating the QFL-ligand are conserved sensors for detecting ERAAP-inhibition. Furthermore, disruption of these mechanisms in ERAAP-deficient mice may result in autoimmune obesity. We will accomplish these goals by (a) characterizing the αβ TCRs and the thymic developmental pathway for QFL-T cells to understand how these cells arise and acquire their unique functions, (b) defining the molecular steps for generating the QFL-ligand by analyzing the processing of Fam49a/b precursors into the FL9 peptide for loading the Qa-1 MHC Ib, and (c) defining the anatomical location(s) and function(s) of QFL-T cells in normal WT mice as well as their obese ERAAP-/- counterparts. Relevance Autoimmunity results when immune tolerance to self-antigens is disrupted. Understanding how self-antigens are produced by proteolytic enzymes will likely reveal potential ways to intervene in autoimmune disorders.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Editorial overview: Nature repeating itself: conformational flexibility determines MHC class I and class II epitope selection.
编辑概述:自然重复:构象灵活性决定 MHC I 类和 II 类表位选择。
DOI: 10.1016/j.coi.2021.07.008
发表时间: 2021
期刊: Current opinion in immunology
影响因子: 7
作者: [Sadegh-Nasseri,Scheherazade, Springer,Sebastian]
通讯作者: Springer,Sebastian
DOI: 10.3389/fimmu.2023.1304798
发表时间: 2023
期刊: Frontiers in immunology
影响因子: 7.3
作者: []
通讯作者:
DOI: 10.1016/j.coi.2021.05.008
发表时间: 2021-06
期刊: Current opinion in immunology
影响因子: 7
作者: [Guan J, Peske JD, Taylor JA, Shastri N]
通讯作者: Shastri N
Unconventional Sources of Peptides for Antigen Presentation
  • 批准号:
    10224701
  • 项目类别:
  • 资助金额:
    $54.3万
  • 财政年份:
    2017
  • 负责人:
    Scheherazade Sadegh-Nasseri
  • 依托单位:
Unconventional Sources of Peptides for Antigen Presentation
  • 批准号:
    9978688
  • 项目类别:
  • 资助金额:
    $54.3万
  • 财政年份:
    2017
  • 负责人:
    Scheherazade Sadegh-Nasseri
  • 依托单位:
Understanding the Impacts of HLA-DO in vivo
  • 批准号:
    9055136
  • 项目类别:
  • 资助金额:
    $40.5万
  • 财政年份:
    2016
  • 负责人:
    Scheherazade Sadegh-Nasseri
  • 依托单位:
Molecular Mechanisms of HLA-DO in Antigen Processing
  • 批准号:
    8520178
  • 项目类别:
  • 资助金额:
    $19.04万
  • 财政年份:
    2012
  • 负责人:
    Scheherazade Sadegh-Nasseri
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: